| 0 (0%) | 11-04 05:07 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.79 | 1-year : | 13.39 |
| Resists | First : | 10.09 | Second : | 11.47 |
| Pivot price | 9.41  |
|||
| Supports | First : | 7.88 | Second : | 6.55 |
| MAs | MA(5) : | 9.7 |
MA(20) : | 9.29 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 31.9 |
D(3) : | 41.4 |
| RSI | RSI(14): 44.1 |
|||
| 52-week | High : | 17.79 | Low : | 7.88 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ VCRE ] has closed above bottom band by 35.0%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 9.6 - 9.66 | 9.66 - 9.7 |
| Low: | 8.98 - 9.05 | 9.05 - 9.11 |
| Close: | 9.06 - 9.17 | 9.17 - 9.25 |
Tue, 03 Nov 2026
Three largest shareholders appoint members to Vicore Pharma (VCRE) nomination committee. - Stock Titan
Tue, 03 Nov 2026
Shareholders can send Vicore annual meeting proposals by Jan. 15, 2027 - Stock Titan
Mon, 02 Nov 2026
Vicore Pharma’s CEO is scheduled for conference appearances in Boston and New York. - Stock Titan
Thu, 22 Oct 2026
VCRE 6-K & SEC Filings - Yahoo Finance
Sat, 10 Oct 2026
Vicore Pharma (VCRE) 10K Form and Latest SEC Filings 2026 - MarketBeat
Fri, 21 Aug 2026
Vicore Pharma (VCRE) Earnings Date and Reports 2026 - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 28 (M) |
| Shares Float | 20 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 1.2 (%) |
| Shares Short | 4 (K) |
| Shares Short P.Month | 12 (K) |
| EPS | -2.04 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -34.4 % |
| Return on Equity (ttm) | -57 % |
| Qtrly Rev. Growth | 26.7 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -283 (M) |
| PE Ratio | -4.5 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|